What question did this study set out to answer?

To evaluate the relationship between baseline haemoglobin levels and oncologic outcomes in patients with intrahepatic cholangiocarcinoma treated with yttrium-90 radioembolisation.

July 1, 2026Journal of Medical Imaging and Radiation Oncology0 citations

View Full Paper

Comment on Baseline Haemoglobin Predicts Oncologic Outcomes in Intrahepatic Cholangiocarcinoma Treated With Yttrium‐90 Radioembolisation: A Retrospective Cohort Study of 136 Patients

AÜAhmet ÜstündağMinistry of Health ÖBÖmer BağcılarUniversity of Freiburg

Key Points

To evaluate the relationship between baseline haemoglobin levels and oncologic outcomes in patients with intrahepatic cholangiocarcinoma treated with yttrium-90 radioembolisation.
Retrospective analysis of 136 patients with intrahepatic cholangiocarcinoma
Assessment of baseline haemoglobin levels and oncologic outcomes post-treatment
Higher baseline haemoglobin levels correlated with improved oncologic outcomes in treated patients.
The specific metrics of improvement in outcomes were not provided in the abstract.

Abstract

Data sharing not applicable to this article as no datasets were generated or analysed during the current study.

Ask AI

Helpful

Bookmark

View Full Paper

Ask AI

Helpful

Bookmark

View Full Paper

Comment on Baseline Haemoglobin Predicts Oncologic Outcomes in Intrahepatic Cholangiocarcinoma Treated With Yttrium‐90 Radioembolisation: A Retrospective Cohort Study of 136 Patients

Key Points

Abstract

Cite This Study

Also Consider

Also Consider